{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:18:09Z","timestamp":1787498289736,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["PB-PG-0817-20044"],"award-info":[{"award-number":["PB-PG-0817-20044"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renal colic is the pain experienced by a patient when a renal calculus (kidney stone) causes partial or complete obstruction of part of the renal outflow tract. The standard analgesic regimes for renal colic are often ineffective; in some studies, less than half of patients achieve complete pain relief, and a large proportion of patients require rescue analgesia within 4 h. Current analgesic regimes are also associated with significant side effects including nausea, vomiting, drowsiness and respiratory depression. It has been hypothesised that beta adrenoreceptor agonists, such as salbutamol, may reduce the pain of renal colic. They have been shown to impact a number of factors that target the physiological causes of pain in renal colic (ureteric spasm and increased peristalsis, increased pressure at the renal pelvis and prostaglandin release with inflammation). There is biological plausibility and a body of evidence sufficient to suggest that this novel treatment for the pain of renal colic should be taken to a phase II clinical trial. The aim of this trial is to test whether salbutamol is an efficacious analgesic adjunct when added to the standard analgesic regime for patients presenting to the ED with subsequently confirmed renal colic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A phase II, randomised, placebo-controlled trial will be performed in an acute NHS Trust in the East Midlands. Patients presenting to the emergency department with pain requiring IV analgesia and working diagnosis of renal colic will be randomised to receive standard analgesia \u00b1 a single intravenous injection of Salbutamol. Secondary study objectives will explore the feasibility of conducting a larger, phase III trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The trial will provide important information about the efficacy of salbutamol as an analgesic adjunct in renal colic. It will also guide the development of a definitive phase III trial to test the cost and clinical effectiveness of salbutamol as an analgesic adjunct in renal colic. Salbutamol benefits from widespread use across the health service for multiple indications, extensive staff familiarity and a good side effect profile; therefore, its potential use for pain relief may have significant benefits for patient care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ISRCTN Registry\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN14552440\">ISRCTN14552440<\/jats:ext-link>\n                      . Registered on 22 July 2019\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06225-9","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T08:04:31Z","timestamp":1650873871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC)"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-6244","authenticated-orcid":false,"given":"Graham","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tabner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Fakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Chester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"3","key":"6225_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ucl.2007.04.003","volume":"34","author":"GC Curhan","year":"2007","unstructured":"Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34(3):287\u201393. https:\/\/doi.org\/10.1016\/j.ucl.2007.04.003.","journal-title":"Urol Clin North Am."},{"issue":"7","key":"6225_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMcp030813","volume":"350","author":"JM Teichman","year":"2004","unstructured":"Teichman JM. Clinical practice. Acute renal colic from ureteral calculus. N Engl J Med. 2004;350(7):684\u201393. https:\/\/doi.org\/10.1056\/NEJMcp030813.","journal-title":"N Engl J Med."},{"key":"6225_CR3","doi-asserted-by":"publisher","first-page":"CD004137","DOI":"10.1002\/14651858.CD004137.pub2","volume":"1","author":"A Holdgate","year":"2004","unstructured":"Holdgate A, Pollock T. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic. Cochrane Database Syst Rev. 2004;1:CD004137. https:\/\/doi.org\/10.1002\/14651858.CD004137.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"6225_CR4","unstructured":"Electronic Medicines Compendium [Internet]. Morphine Sulfate 10mg\/ml Injection BP. Updated 2022 Feb 22. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2244\/smpc#gref. Accessed 14 Apr 2022."},{"key":"6225_CR5","unstructured":"Electronic Medicines Compendium [Internet]. Voltarol 100 mg Suppositories. Updated 2021 Oct 21. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/7859\/smpc. Accessed 14 Apr 2022."},{"key":"6225_CR6","unstructured":"Tabner A. Patient and Public Involvement meeting summary - SARC. 2014:1-5."},{"issue":"5","key":"6225_CR7","doi-asserted-by":"publisher","first-page":"1266e1","DOI":"10.1016\/j.urology.2010.12.045","volume":"77","author":"I Wanajo","year":"2011","unstructured":"Wanajo I, Tomiyama Y, Yamazaki Y, Kojima M. Ureteral selectivity of intravenous beta-adrenoceptor agonists in pig model of acute ureteral obstruction: comparison of KUL-7211, a selective beta2\/beta3 agonist, with isoproterenol, terbutaline, and CL-316243. Urology. 2011;77(5):1266e1\u20136.","journal-title":"Urology."},{"issue":"6","key":"6225_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00240-005-0475-5","volume":"33","author":"I Wanajo","year":"2005","unstructured":"Wanajo I, Tomiyama Y, Tadachi M, Kobayashi M, Yamazaki Y, Kojima M, et al. The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics. Urol Res. 2005;33(6):409\u201314. https:\/\/doi.org\/10.1007\/s00240-005-0475-5.","journal-title":"Urol Res."},{"issue":"4","key":"6225_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1254\/jphs.92.411","volume":"92","author":"Y Tomiyama","year":"2003","unstructured":"Tomiyama Y, Murakami M, Hayakawa K, Akiyama K, Yamazaki Y, Kojima M, et al. Pharmacological profile of KUL-7211, a selective beta-adrenoceptor agonist, in isolated ureteral smooth muscle. J Pharmacol Sci. 2003;92(4):411\u20139. https:\/\/doi.org\/10.1254\/jphs.92.411.","journal-title":"J Pharmacol Sci."},{"issue":"5","key":"6225_CR10","first-page":"B4642","volume":"60","author":"JS Jakobsen","year":"2013","unstructured":"Jakobsen JS. Endoluminal pharmacologic stimulation of the upper urinary tract. Dan Med J. 2013;60(5):B4642.","journal-title":"Dan Med J."},{"key":"6225_CR11","unstructured":"Electronic Medicines Compendium [Internet]. Ventolin 500 micrograms Injection. Updated 2021 Feb 19. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2192\/smpc. Accessed 14 Apr 2022."},{"issue":"5","key":"6225_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/ph3051304","volume":"3","author":"K Davenport","year":"2010","unstructured":"Davenport K, Waine E. The role of non-steroidal anti-inflammatory drugs in renal colic. Pharmaceuticals (Basel). 2010;3(5):1304\u201310. https:\/\/doi.org\/10.3390\/ph3051304.","journal-title":"Pharmaceuticals (Basel)."},{"key":"6225_CR13","doi-asserted-by":"crossref","unstructured":"Matsumoto R, Otsuka A, Suzuki T, Shinbo H, Mizuno T, Kurita Y, et al. Expression and functional role of \u03b23 -adrenoceptors in the human ureter. 2013;20:1007-14.","DOI":"10.1111\/iju.12093"},{"issue":"4","key":"6225_CR14","first-page":"363","volume":"113","author":"IS Mudraia","year":"1992","unstructured":"Mudraia IS, Kirpatovskii VI. Adrenergic regulation of the contractility of the human and canine ureters. Biull Eksp Biol Med. 1992;113(4):363\u20135.","journal-title":"Biull Eksp Biol Med."},{"key":"6225_CR15","first-page":"1364","volume":"164","author":"YC Park","year":"2000","unstructured":"Park YC, Tomiyama Y, Hayakawa K, Akahane M, Ajisawa Y, Miyatake R, et al. Existence of a beta3-adrenoceptor and its functional role in the human ureter. Int J Urol. 2000;164:1364\u201370.","journal-title":"Int J Urol"},{"issue":"6","key":"6225_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00240-006-0069-x","volume":"34","author":"HU Jung","year":"2006","unstructured":"Jung HU, Frimodt-Moller PC, Osther PJ, Mortensen J. Pharmacological effect on pyeloureteric dynamics with a clinical perspective: a review of the literature. Urol Res. 2006;34(6):341\u201350. https:\/\/doi.org\/10.1007\/s00240-006-0069-x.","journal-title":"Urol Res."},{"issue":"2","key":"6225_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0022-5347(05)66049-1","volume":"166","author":"H Danuser","year":"2001","unstructured":"Danuser H, Weiss R, Abel D, Walter B, Scholtysik G, Mettler D, et al. Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions. J Urol. 2001;166(2):714\u201320. https:\/\/doi.org\/10.1016\/S0022-5347(05)66049-1.","journal-title":"J Urol."},{"issue":"6","key":"6225_CR18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.eururo.2008.03.092","volume":"54","author":"H Jung","year":"2008","unstructured":"Jung H, Norby B, Frimodt-Moller PC, Osther PJ. Endoluminal isoproterenol irrigation decreases renal pelvic pressure during flexible ureterorenoscopy: a clinical randomized, controlled study. Eur Urol. 2008;54(6):1404\u201313. https:\/\/doi.org\/10.1016\/j.eururo.2008.03.092.","journal-title":"Eur Urol."},{"issue":"5","key":"6225_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2125.1986.tb02939.x","volume":"22","author":"DJ Morgan","year":"1986","unstructured":"Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol. 1986;22(5):587\u201393. https:\/\/doi.org\/10.1111\/j.1365-2125.1986.tb02939.x.","journal-title":"Br J Clin Pharmacol."},{"issue":"6","key":"6225_CR20","doi-asserted-by":"publisher","first-page":"e011315","DOI":"10.1136\/bmjopen-2016-011315","volume":"6","author":"AJ Tabner","year":"2016","unstructured":"Tabner AJ, Johnson GD, Fakis A, Surtees J, Lennon RI. \u03b2-Adrenoreceptor agonists in the management of pain associated with renal colic: a systematic review. BMJ Open. 2016;6(6):e011315. https:\/\/doi.org\/10.1136\/bmjopen-2016-011315.","journal-title":"BMJ Open."},{"key":"6225_CR21","first-page":"CD008509-CD","volume":"4","author":"T Campschroer","year":"2014","unstructured":"Campschroer T, Zhu Y, Duijvesz D, Grobbee DE, Lock MTWT. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev. 2014;4:CD008509-CD.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9991","key":"6225_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(15)60933-3","volume":"386","author":"R Pickard","year":"2015","unstructured":"Pickard R, Starr K, MacLennan G, Lam T, Thomas R, Burr J, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet. 2015;386(9991):341\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(15)60933-3.","journal-title":"Lancet."},{"issue":"5","key":"6225_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1152\/ajplegacy.1973.224.5.1054","volume":"224","author":"DG McLeod","year":"1973","unstructured":"McLeod DG, Reynolds DG, Swan KG. Adrenergic mechanisms in the canine ureter. Am J Physiol. 1973;224(5):1054\u20138. https:\/\/doi.org\/10.1152\/ajplegacy.1973.224.5.1054.","journal-title":"Am J Physiol."},{"issue":"5","key":"6225_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000281095","volume":"40","author":"S Kondo","year":"1985","unstructured":"Kondo S, Morita T, Saeki H, Tsuchida S. Effects of autonomic drugs on in vivo recording of electromyograms of canine renal pelvis and ureter. Urol Int. 1985;40(5):260\u20136. https:\/\/doi.org\/10.1159\/000281095.","journal-title":"Urol Int."},{"issue":"3","key":"6225_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1620\/tjem.146.265","volume":"146","author":"T Morita","year":"1985","unstructured":"Morita T, Suzuki T, Kondo S, Saeki H, Nishimoto T, Tsuchida S. Relationship between pelviureteral peristaltic frequency and urine flow change evoked by autonomic drug administration. Tohoku J Exp Med. 1985;146(3):265\u201371. https:\/\/doi.org\/10.1620\/tjem.146.265.","journal-title":"Tohoku J Exp Med."},{"issue":"1","key":"6225_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/MOU.0000000000000235","volume":"26","author":"PJ Osther","year":"2015","unstructured":"Osther PJ, Pedersen KV, Lildal SK, Pless MS, Andreassen KH, Osther SS, et al. Pathophysiological aspects of ureterorenoscopic management of upper urinary tract calculi. Curr Opin Urol. 2015;26(1):63\u20139. https:\/\/doi.org\/10.1097\/MOU.0000000000000235.","journal-title":"Curr Opin Urol."},{"key":"6225_CR27","unstructured":"Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press."},{"issue":"3","key":"6225_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/emj.17.3.188","volume":"17","author":"P Ahee","year":"2000","unstructured":"Ahee P, Crowe AV. The management of hyperkalaemia in the emergency department. J Accid Emerg Med. 2000;17(3):188\u201391. https:\/\/doi.org\/10.1136\/emj.17.3.188.","journal-title":"J Accid Emerg Med."},{"key":"6225_CR29","unstructured":"MHRA. Risk-adapted approaches to the management of clinical trials of investigational medicinal products. 2011. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/343677\/Risk-adapted_approaches_to_the_management_of_clinical_trials_of_investigational_medicinal_products.pdf. Accessed 14 Apr 2022."},{"key":"6225_CR30","unstructured":"Royal College of Emergency Medicine. Management and Transfer of Patients with a Diagnosis of Ruptured Abdominal Aortic Aneurysm to a Specialist Vascular Centre. 2019. Available from: https:\/\/rcem.ac.uk\/wp-content\/uploads\/2021\/10\/RCEM_BPC_rAAA_220119_FINAL.pdf. Accessed 14 Apr 2022."},{"key":"6225_CR31","unstructured":"Electronic Medicines Compendium [Internet]. Timolol 0.25% w\/v Eye Drops Solution. Updated 2020 Feb 17. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/10889\/smpc. Accessed 14 Apr 2022."},{"key":"6225_CR32","doi-asserted-by":"publisher","unstructured":"Machin D, Campbell MJ, Tan SB, Tan SH. Sample size tables for clinical studies [Internet]. 3rd ed. 2008. https:\/\/doi.org\/10.1002\/9781444300710.","DOI":"10.1002\/9781444300710"},{"issue":"4","key":"6225_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0196-0644(96)70238-X","volume":"27","author":"KH Todd","year":"1996","unstructured":"Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996;27(4):485\u20139. https:\/\/doi.org\/10.1016\/S0196-0644(96)70238-X.","journal-title":"Ann Emerg Med."},{"issue":"6","key":"6225_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1067\/mem.2001.118863","volume":"38","author":"EJ Gallagher","year":"2001","unstructured":"Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38(6):633\u20138. https:\/\/doi.org\/10.1067\/mem.2001.118863.","journal-title":"Ann Emerg Med."},{"issue":"4","key":"6225_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S2213-2600(13)70070-5","volume":"1","author":"S Goodacre","year":"2013","unstructured":"Goodacre S, Cohen J, Bradburn M, Gray A, Benger J, Coats T, et al. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3\u2009Mg trial): a double-blind, randomised controlled trial. Lancet Respir Med. 2013;1(4):293\u2013300. https:\/\/doi.org\/10.1016\/S2213-2600(13)70070-5.","journal-title":"Lancet Respir Med."},{"issue":"8","key":"6225_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00228-007-0322-4","volume":"63","author":"J Sanchez-Carpena","year":"2007","unstructured":"Sanchez-Carpena J, Dominguez-Hervella F, Garcia I, Gene E, Bugarin R, Martin A, et al. Comparison of intravenous dexketoprofen and dipyrone in acute renal colic. Eur J Clin Pharmacol. 2007;63(8):751\u201360. https:\/\/doi.org\/10.1007\/s00228-007-0322-4.","journal-title":"Eur J Clin Pharmacol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06225-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T08:06:38Z","timestamp":1650873998000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06225-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6225"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06225-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has received ethical approval from West of Scotland REC 1 (19\/WS\/0087), in addition to the approval from the Medicines for Human Use Regulatory Authority (MHRA) (CTA 17854\/0206\/001-0001) and the Health Research Authority (HRA). The IRAS project ID is 252075 and EudraCT: 2018-004305-11.Written, informed consent to participate will be sought from all participants prior to any study-related activities taking place. The trial consent form is available on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"This section is not applicable to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"352"}}